ES2069345T3 - Analogos heterociclicos de amida-prostaglandina 7-oxabiciclo-heptil-sustituidos utiles en el tratamiento de enfermedades tromboticas y vasoespasticas. - Google Patents

Analogos heterociclicos de amida-prostaglandina 7-oxabiciclo-heptil-sustituidos utiles en el tratamiento de enfermedades tromboticas y vasoespasticas.

Info

Publication number
ES2069345T3
ES2069345T3 ES92108848T ES92108848T ES2069345T3 ES 2069345 T3 ES2069345 T3 ES 2069345T3 ES 92108848 T ES92108848 T ES 92108848T ES 92108848 T ES92108848 T ES 92108848T ES 2069345 T3 ES2069345 T3 ES 2069345T3
Authority
ES
Spain
Prior art keywords
analogs
oxabiciclo
heptil
prostaglandina
amida
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92108848T
Other languages
English (en)
Inventor
Steven E Hall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of ES2069345T3 publication Critical patent/ES2069345T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

SE SUMINISTRAN ANALOGOS DE LA PROSTAGLANDINA DE AMIDO HETEROCICLICO SUBSTITUIDO CON 7 NISTAS RECEPTORES DEL TROMBOXANO A SUB 2 (TXA SUB 2) O COMBINADAMENTE INHIBIDORES DE LA SINTETASA DEL TROMBOXANO Y ANTAGONISTAS RECEPTORES DEL TROMBOXANO A SUB 2 Y TIENEN LA FORMULA ESTRUCTURAL: EN LA QUE R ES SO3H, P(O)OR3OH O P(O)R4OH, X ES O O NH, Y Z, R1, R2, R3 Y R4 SE DEFINEN EN LAS ESPECIFICACIONES.
ES92108848T 1991-06-12 1992-05-26 Analogos heterociclicos de amida-prostaglandina 7-oxabiciclo-heptil-sustituidos utiles en el tratamiento de enfermedades tromboticas y vasoespasticas. Expired - Lifetime ES2069345T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/713,898 US5158967A (en) 1991-06-12 1991-06-12 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease

Publications (1)

Publication Number Publication Date
ES2069345T3 true ES2069345T3 (es) 1995-05-01

Family

ID=24867989

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92108848T Expired - Lifetime ES2069345T3 (es) 1991-06-12 1992-05-26 Analogos heterociclicos de amida-prostaglandina 7-oxabiciclo-heptil-sustituidos utiles en el tratamiento de enfermedades tromboticas y vasoespasticas.

Country Status (8)

Country Link
US (1) US5158967A (es)
EP (1) EP0518118B1 (es)
JP (1) JPH05194524A (es)
AT (1) ATE119532T1 (es)
CA (1) CA2070895A1 (es)
DE (1) DE69201596T2 (es)
DK (1) DK0518118T3 (es)
ES (1) ES2069345T3 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5347007A (en) * 1992-03-06 1994-09-13 E. R. Squibb & Sons, Inc. Method of preparing 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5260448A (en) * 1992-03-06 1993-11-09 E. R. Squibb & Sons, Inc. Method for preparing 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5260449A (en) * 1992-08-12 1993-11-09 E. R. Squibb & Sons, Inc. Method for preparing 7-oxabicycloheptyl substituted bromooxazole amide prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds
CA2123890C (en) * 1992-09-18 1998-01-20 Kiyotaka Ohno Novel sulfonic acid derivative and medicinal use thereof
JPH08501564A (ja) * 1992-09-22 1996-02-20 セル・セラピューティックス・インコーポレーテッド 新規なエポキシド含有化合物
US5866576A (en) * 1992-12-16 1999-02-02 Cell Therapeutics, Inc. Epoxide-containing compounds
US5849922A (en) * 1996-05-31 1998-12-15 Eli Lilly And Company Preparation of substituted alkenoic acids
US5849766A (en) * 1996-05-31 1998-12-15 Eli Lilly And Company Carbamoyl substituted heterocycles
WO2009089098A1 (en) 2008-01-03 2009-07-16 Musc Foundation For Research Development Methods for the treatment of cancers
CN117122687A (zh) 2017-11-29 2023-11-28 凡德贝尔大学 抑制肿瘤移转的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3922301A (en) * 1973-06-19 1975-11-25 Ono Pharmaceutical Co Sulphonic acid derivatives of prostaglandins
US4418076A (en) * 1982-05-03 1983-11-29 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane hydrazone prostaglandin analogs useful in treating thrombolytic diseases
US4416896A (en) * 1982-05-17 1983-11-22 E. R. Squibb & Sons, Inc. 7-Oxabicyclopheptane substituted amino prostaglandin analogs useful in the treatment of thrombolytic disease
US4556675A (en) * 1982-05-17 1985-12-03 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene compounds
US4463015A (en) * 1982-08-18 1984-07-31 E. R. Squibb & Sons, Inc. Aryl substituted 7-oxabicycloheptane compounds, useful in inhibiting platelet aggregation
US4474804A (en) * 1983-09-19 1984-10-02 E. R. Squibb & Sons, Inc. 7-Oxabicyclo substituted prostaglandin phenyl carboxylic acid derivatives useful as cardiovascular agents
US4522949A (en) * 1983-10-20 1985-06-11 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted prostaglandin interphenylene analogs useful as cardiovascular agents
US4536513A (en) * 1984-03-14 1985-08-20 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted prostaglandin interphenylene analogs useful in the treatment of thrombolytic disease
US4663336A (en) * 1985-07-01 1987-05-05 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted diamide and its congener prostaglandin analogs useful in the treatment of thrombotic disease
US4663337A (en) * 1986-04-18 1987-05-05 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amides useful in the treatment of thrombotic disease
US5100889A (en) * 1989-04-03 1992-03-31 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
ZA899868B (en) * 1988-12-23 1990-09-26 Squibb & Sons Inc 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
NZ232897A (en) * 1989-04-03 1992-12-23 Squibb & Sons Inc Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogues, preparation and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
CA2070895A1 (en) 1992-12-13
DK0518118T3 (da) 1995-05-22
ATE119532T1 (de) 1995-03-15
EP0518118B1 (en) 1995-03-08
DE69201596T2 (de) 1995-09-07
EP0518118A1 (en) 1992-12-16
JPH05194524A (ja) 1993-08-03
DE69201596D1 (de) 1995-04-13
US5158967A (en) 1992-10-27

Similar Documents

Publication Publication Date Title
DK0675886T3 (da) Aminomethylensubstituerede ikke-aromatiske heterocykler og deres anvendelse som substance P-antagonister
IS6275A (is) Heteróhringa efnasambönd og notkun þeirra sem mótlyf efnaskiptaglútamatviðtaka
CY1107001T1 (el) Αζωτουχα ετεροκυκλικα παραγωγα καρβοξαμιδιου ή αλας αυτων ως αντιϊκοι παραγοντες
DK260588A (da) Heterocykliske ketoner
EA200300982A1 (ru) Гетероциклические производные для лечения рака и других пролиферативных заболеваний
ES2069345T3 (es) Analogos heterociclicos de amida-prostaglandina 7-oxabiciclo-heptil-sustituidos utiles en el tratamiento de enfermedades tromboticas y vasoespasticas.
ATE272617T1 (de) Sulfonamid-derivate
AU8811401A (en) Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
NO20000737D0 (no) Tetrahydro <gamma>-karboliner
DK0453960T3 (da) Sulfonylamino-substituerede bicykliske hydroxamsyrederivater
DE69329184D1 (de) Alkylsubstituierte heterocyclische Verbindungen
ES2132245T3 (es) Derivados de 1-azaadamantano como agonistas o antagonistas de 5-ht.
DK0648762T3 (da) Bicykliske forbindelser som excitatoriske aminosyrereceptorantagonister
DE69319900T2 (de) N,n'-disubstituierte amidderivate
FI883134A (fi) Fluorhaltiga renin-inhibitorer.
PA8525601A1 (es) Profarmacos de (3s,4s)-4-bencil-1-[2-(4-hidroxi-bencenosulfonil)-etil]-piperidin-3-ol
DE60013515D1 (de) 4-Arylpiperidinderivate zur Behandlung von Pruritus
DE69527854D1 (de) Derivate substituierter amidinonaphthylester
ATE92496T1 (de) Pradimicin-derivate.
ATE114309T1 (de) N-azabicyclo(3.3.0>octanamide von aromatischen säuren.
TH51662A (th) ไวโทรเนคทิน รีเซปเตอร์ แอนทากอนิสท์

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 518118

Country of ref document: ES